Nvidia Leverages Generative AI for Biology with BioNeMo

The Intelligent Security Summit is the place to learn about the critical role of AI & ML in cybersecurity and industry-specific case studies. Now you can watch on-demand sessions from the summit and explore the infinite possibilities of modern AI and ML.

Earlier this year, Nvidia announced the launch of its BioNeMo Large Language Model (LLM) service to help researchers build new AI models for biology. BioNeMo was used to help build a new generative AI model that could have a significant impact on helping improve human health as well as climate change. The generative AI model was used to create a pair of new proteins that are being detailed today. One of the proteins could one day be used to reduce carbon dioxide, while the other might help to cure congenital diseases.

Life science vendor Absci recently announced that it has built a generative AI model using E. coli bacteria that can create entirely new antibody drugs. IBM has developed an open-source library called Generative Toolkit for Scientific Discovery (GT4SD) to help advance efforts as well. These AI-driven technologies are revolutionizing drug discovery, reducing the time it takes to create new treatments.

Using Nvidia BioNeMo, Evozyne and Nvidia were able to fine-tune Prot-VAE for a specific protein family. Once it was fine-tuned, the new model has been used to generate an entirely new library of proteins that maintain or enhance a function in a specific family class of proteins. This model was able to invent proteins never before seen in nature, unlocking the potential for new therapies in materials, energy sources, and sustainable foods.

At the Intelligent Security Summit, you can learn more about how AI and ML are revolutionizing healthcare, drug discovery, and cybersecurity. Watch on-demand sessions from the summit today and discover the incredible possibilities of modern AI and ML.

Categorized as AI

Leave a comment

Your email address will not be published. Required fields are marked *